119 related articles for article (PubMed ID: 2485269)
1. The implication of bilitranslocase function in the impaired rifamycin SV metabolism in Gilbert's syndrome.
Gentile S; Persico M; Baldini G; Lunazzi G; Tiribelli C; Sottocasa GL
Clin Sci (Lond); 1985 Jun; 68(6):675-80. PubMed ID: 2485269
[TBL] [Abstract][Full Text] [Related]
2. Sex differences of nicotinate-induced hyperbilirubinemia in Gilbert's syndrome. Implication of bilitranslocase function.
Gentile S; Tiribelli C; Baldini G; Lunazzi G; Sottocasa GL
J Hepatol; 1985; 1(4):417-29. PubMed ID: 3840503
[TBL] [Abstract][Full Text] [Related]
3. Abnormal hepatic uptake of low doses of sulfobromophthalein in Gilbert's syndrome: the role of reduced affinity of the plasma membrane carrier of organic anions.
Gentile S; Persico M; Tiribelli C
Hepatology; 1990 Aug; 12(2):213-7. PubMed ID: 2391064
[TBL] [Abstract][Full Text] [Related]
4. Gilbert's syndrome and drug metabolism.
Macklon AF; Savage RL; Rawlins MD
Clin Pharmacokinet; 1979; 4(3):223-32. PubMed ID: 383356
[TBL] [Abstract][Full Text] [Related]
5. Abnormal hepatic transport of indocyanine green in Gilbert's syndrome.
Martin JF; Vierling JM; Wolkoff AW; Scharschmidt BF; Vergalla J; Waggoner JG; Berk PD
Gastroenterology; 1976 Mar; 70(3):385-91. PubMed ID: 814028
[TBL] [Abstract][Full Text] [Related]
6. Impaired plasma clearance of nicotinic acid and rifamycin-SV in Gilbert's syndrome: evidence of a functional heterogeneity.
Gentile S; Marmo R; Persico M; Bronzino P; Coltorti M
Hepatogastroenterology; 1985 Jun; 32(3):113-6. PubMed ID: 4018705
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's syndrome).
Posner J; Cohen AF; Land G; Winton C; Peck AW
Br J Clin Pharmacol; 1989 Jul; 28(1):117-20. PubMed ID: 2775610
[TBL] [Abstract][Full Text] [Related]
8. Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1.
Persico M; Persico E; Bakker CT; Rigato I; Amoroso A; Torella R; Bosma PJ; Tiribelli C; Ostrow JD
Hepatology; 2001 Mar; 33(3):627-32. PubMed ID: 11230743
[TBL] [Abstract][Full Text] [Related]
9. Alteration of drug metabolism in Gilbert's syndrome.
Carulli N; Ponz de Leon M; Mauro E; Manenti F; Ferrari A
Gut; 1976 Aug; 17(8):581-7. PubMed ID: 976795
[TBL] [Abstract][Full Text] [Related]
10. Serum free fatty acids and bilirubin concentration during fasting in patients with Gilbert's syndrome and normal controls.
Orzes N; Tamaro G; Parco S; Baldini G; Lunazzi GC; Sottocasa GL; Mangiarotti MA; Tiribelli C
Ric Clin Lab; 1987; 17(1):61-6. PubMed ID: 3589403
[TBL] [Abstract][Full Text] [Related]
11. Definition of a conjugation of dysfunction in Gilbert's syndrome: studies of the handling of bilirubin loads and of the pattern of bilirubin conjugates secreted in bile.
Goresky CA; Gordon ER; Shaffer EA; Paré P; Carassavas D; Aronoff A
Clin Sci Mol Med; 1978 Jul; 55(1):63-71. PubMed ID: 668269
[TBL] [Abstract][Full Text] [Related]
12. Plasma sulfobromophthalein disappearance in Gilbert's syndrome.
Serra MA; Aparisi L; García F; Del Olmo JA; Gilabert MS; Rodríguez F; Escudero A; Wassel A; Rodrigo JM
Hepatogastroenterology; 1997; 44(13):210-4. PubMed ID: 9058146
[TBL] [Abstract][Full Text] [Related]
13. Sites of competition in the selective hepatic uptake of rifamycin-SV, flavaspidic acid, bilirubin, and bromsulphthalein.
Kenwright S; Levi AJ
Gut; 1974 Mar; 15(3):220-6. PubMed ID: 4842968
[TBL] [Abstract][Full Text] [Related]
14. Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study.
McDonald GB; Evans AT; McCune JS; Schoch G; Ostrow JD; Gooley TA
Lancet Haematol; 2016 Nov; 3(11):e516-e525. PubMed ID: 27968820
[TBL] [Abstract][Full Text] [Related]
15. Bromsulfophthalein clearance and aminopyrine test in patients with Gilbert's syndrome.
Bar-Meir S; Bar-Tal L; Papa MZ; Peled Y
Isr J Med Sci; 1986 May; 22(5):376-9. PubMed ID: 3744786
[TBL] [Abstract][Full Text] [Related]
16. Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome.
Wallner M; Bulmer AC; Mölzer C; Müllner E; Marculescu R; Doberer D; Wolzt M; Wagner OF; Wagner KH
Eur J Clin Invest; 2013 Sep; 43(9):912-9. PubMed ID: 23865893
[TBL] [Abstract][Full Text] [Related]
17. Population studies on Gilbert's syndrome.
Owens D; Evans J
J Med Genet; 1975 Jun; 12(2):152-6. PubMed ID: 1142378
[TBL] [Abstract][Full Text] [Related]
18. Effect of clofibrate on the metabolism of bilirubin, bromosulphophthalein and indocyanine green and on the biliary lipid composition in Gilbert's syndrome.
Kutz K; Kandler H; Gugler R; Fevery J
Clin Sci (Lond); 1984 Apr; 66(4):389-97. PubMed ID: 6697662
[TBL] [Abstract][Full Text] [Related]
19. Delayed gastric emptying in subjects with Gilbert's syndrome.
Méndez-Sánchez N; González V; Flores A; Martínez M; Graef A; Uribe M
Hepatogastroenterology; 2001; 48(40):1183-5. PubMed ID: 11490829
[TBL] [Abstract][Full Text] [Related]
20. Effect of cimetidine on the metabolism of cholephilic dyes in Gilbert's syndrome.
Kutz K; Deres M
Eur J Clin Pharmacol; 1984; 27(2):227-32. PubMed ID: 6499902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
